Sphere Medical Holding (LSE:SPHR) EV-to-EBITDA : 0.54 (As of Jun. 11, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sphere Medical Holding's enterprise value is £-2.67 Mil. Sphere Medical Holding's EBITDA for the trailing twelve months (TTM) ended in Dec. 2016 was £-4.99 Mil. Therefore, Sphere Medical Holding's EV-to-EBITDA for today is 0.54.

The historical rank and industry rank for Sphere Medical Holding's EV-to-EBITDA or its related term are showing as below:

LSE:SPHR' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2.7 Med: -0.3 Max: 1.6
Current: 0.53

During the past 9 years, the highest EV-to-EBITDA of Sphere Medical Holding was 1.60. The lowest was -2.70. And the median was -0.30.

LSE:SPHR's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 15.41 vs LSE:SPHR: 0.53

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-11), Sphere Medical Holding's stock price is £0.00. Sphere Medical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.030. Therefore, Sphere Medical Holding's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Sphere Medical Holding EV-to-EBITDA Historical Data

The historical data trend for Sphere Medical Holding's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding EV-to-EBITDA Chart

Sphere Medical Holding Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

EV-to-EBITDA

Get a 7-Day Free Trial

-2.68

-1.42

-1.78

-0.93

-1.91

Sphere Medical Holding Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
EV-to-EBITDA	Get a 7-Day Free Trial						-1.78	-	-0.93	-	-1.91

Competitive Comparison of Sphere Medical Holding's EV-to-EBITDA

For the Medical Devices subindustry, Sphere Medical Holding's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sphere Medical Holding's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's EV-to-EBITDA falls into.

Sphere Medical Holding EV-to-EBITDA Calculation

Sphere Medical Holding's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	-2.674	/	-4.992
	=	0.54

Sphere Medical Holding's current Enterprise Value is £-2.67 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's EBITDA for the trailing twelve months (TTM) ended in Dec. 2016 was £-4.99 Mil.

Sphere Medical Holding (LSE:SPHR) EV-to-EBITDA Explanation

Sphere Medical Holding's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.00	/	-0.030
	=	At Loss

Sphere Medical Holding's share price for today is £0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.030.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Sphere Medical Holding EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Sphere Medical Holding (LSE:SPHR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harston Mill, Harston, Cambridge, GBR, CB22 7GG

Website

http://www.spheremedical.com

Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.